Our data suggest that the intestinal microbial profiles may help evaluating and managing the UCBT outcome in pediatric CD patients with IL10RA deficiency and those with primary immunodeficiency and severe malnutrition. This evidence concerns the gene IL10RA and hyperinsulinemic hypoglycemia, familial, 4.